# Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

> **NCT00981318** · PHASE4 · TERMINATED · sponsor: **Rodwick, Barry M., M.D.** · enrollment: 3 (actual)

## Conditions studied

- HIV Infections
- Acquired Immunodeficiency Syndrome

## Interventions

- **DRUG:** lopinavir/ritonavir plus maraviroc

## Key facts

- **NCT ID:** NCT00981318
- **Lead sponsor:** Rodwick, Barry M., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** unable to enroll expected number of subjects
- **Last updated:** 2015-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981318, "Pilot Assessment of Lopinavir/Ritonavir and Maraviroc". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00981318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*